Cargando…
Uncertain Associations of Major Bleeding and Concurrent Use of Antiplatelet Agents and Chinese Medications: A Nested Case-Crossover Study
Despite the evidence that some commonly used Chinese medications (CMs) have antiplatelet/anticoagulant effects, many patients still used antiplatelets combined with CMs. We conducted a nested case-crossover study to examine the associations between the concomitant use of antiplatelets and CMs and ma...
Autores principales: | Tsai, Hsin-Hui, Lin, Hsiang-Wen, Tsai, Chiu-Lin, Yam, Felix K., Lin, Sheng-Shing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558644/ https://www.ncbi.nlm.nih.gov/pubmed/28831288 http://dx.doi.org/10.1155/2017/9417186 |
Ejemplares similares
-
A Review of Potential Harmful Interactions between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines
por: Tsai, Hsin-Hui, et al.
Publicado: (2013) -
Antiplatelets/enoxaparin-sodium: Major bleeding: case report
Publicado: (2020) -
Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents
por: Oh, Hyoung-Chul, et al.
Publicado: (2018) -
Bleeding risk with dabigatran, rivaroxaban, warfarin, and antiplatelet agent in Asians with non-valvular atrial fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2017) -
Concurrent use of Chinese herbal medicine and anticoagulants may reduce major bleeding events
por: Hsu, Shuo-Min, et al.
Publicado: (2022)